Olaplex Holdings (OLPX) announced the acquisition of Purvala Bioscience, a Boston-based biotech company. The company noted that this marks the first acquisition from OLAPLEX since the brand launched over ten years ago.
OLAPLEX CEO Amanda Baldwin said: "What we've accomplished to-date has already left such a meaningful impact on our industry, and we believe that with Purvala we have the potential to create the next generation of disruptive science-backed product innovation alongside our patent-protected bond-building technology, Bis-amino."
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.